Literature DB >> 7364824

Prognosis in infantile idiopathic scoliosis.

S K Thompson, G Bentley.   

Abstract

A review was performed of 86 cases of infantile idiopathic scoliosis treated between 1962 and 1979. The single primary curves were classified as resolving, stable, progressive with a low rib--vertebra angle difference (RVAD) and progressive with a high RVAD. Two single primary curves subsequently developed a second curve and 17 were double when first diagnosed. Prognosis was difficult to establish before the age of five years. Only 18 per cent of curves showing progression beyond 50 degrees reached that point before the age of four. Conversely, if a scoliosis of 50 degrees or more was present before the age of four it always progressed. A more favourable outcome was indicated by male sex, a left-sided curve, a low initial curve measurement, an RVAD of less than 20 degrees in the initial radiograph, and the onset of scoliosis in the first year of life.

Entities:  

Mesh:

Year:  1980        PMID: 7364824

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  4 in total

1.  Patterns of postural asymmetry in infants: a standardized video-based analysis.

Authors:  Heike Philippi; Andreas Faldum; Tatjana Jung; Holger Bergmann; Katharina Bauer; Daniela Gross; Juergen Spranger
Journal:  Eur J Pediatr       Date:  2005-11-10       Impact factor: 3.183

Review 2.  Epidemiology of adolescent idiopathic scoliosis.

Authors:  Markus Rafael Konieczny; Hüsseyin Senyurt; Rüdiger Krauspe
Journal:  J Child Orthop       Date:  2012-12-11       Impact factor: 1.548

3.  Infantile Idiopathic Scoliosis: Outcomes of Brace Treatment until Skeletal Maturity or Spinal Fusion.

Authors:  Taher Babaee; Mojtaba Kamyab; Mohammad Saleh Ganjavian
Journal:  Arch Bone Jt Surg       Date:  2020-11

4.  Treatment of infantile idiopathic scoliosis using a novel thoracolumbosacral orthosis: a case report.

Authors:  Jeb McAviney; Benjamin T Brown
Journal:  J Med Case Rep       Date:  2022-01-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.